COMPARATIVE-STUDY OF THE EFFICACY OF KETOPROFEN ACCORDING TO THE ROUTE OF ADMINISTRATION (INTRAMUSCULAR OR ORAL) - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH RHEUMATOID-ARTHRITIS

被引:0
|
作者
DOUGADOS, M
LISTRAT, V
DUCHESNE, L
AMOR, B
机构
来源
REVUE DU RHUMATISME | 1992年 / 59卷 / 11期
关键词
KETOPROFEN; RHEUMATOID ARTHRITIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence of the analgesic effects of nonsteroidal antiinflammatory drugs in human diseases is easy to collect. However, demonstration of differences in the activity of NSAIDs according to the route of administration is considerably more difficult. Forty patients with rheumatoid arthritis were given either one intramuscular injection of 100 mg ketoprofen with two placebo capsules or one intramuscular injection of placebo with two 50 mg ketoprofen capsules. Analysis of changes in pain severity over the six-hour study period failed to disclose any statistically significant differences between the two groups. However, time to peak effectiveness (Tmax) was significantly shorter with the intramuscular route (194 +/- 118 minutes) than with the oral route (276 +/- 111 minutes) (p = 0.029). Although intramuscular NSAID therapy is rarely warranted in RA patients, these findings suggest that RA may serve as a clinical model for evaluating the effectiveness of a NSAID according to the route of administration.
引用
收藏
页码:769 / 773
页数:5
相关论文
共 50 条
  • [21] A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: A 12-week, double-blind, randomized, placebo-controlled study
    Lan, JL
    Chou, SJ
    Chen, DY
    Chen, YH
    Hsieh, TY
    Young, M
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (08) : 618 - 623
  • [22] Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study
    Leng, Xiaomei
    Lin, Wei
    Liu, Shixue
    Kanik, Keith
    Wang, Cunshan
    Wan, Weiguo
    Jiang, Zhenyu
    Liu, Yi
    Liu, Shengyun
    Zhang, Zhuoli
    Zhang, Zhiyi
    Xu, Jian
    Tan, Wenfeng
    Hu, Jiankang
    Li, Jingyang
    Liu, Ju
    Gunay, Levent M.
    Dina, Oluwaseyi
    Kinch, Cassandra
    Zeng, Xiaofeng
    RMD OPEN, 2023, 9 (01):
  • [23] Therapeutic efficacy of Urtica dioica and evening primrose in patients with rheumatoid arthritis: A randomized double-blind, placebo-controlled clinical trial
    Abd-Nikfarjam, Bahareh
    Abbasi, Mahnaz
    Memarzadeh, Mohammadreza
    Farzam, Seyed-Amir
    Jamshidian, Azam
    Dolati-Somarin, Amirhossein
    JOURNAL OF HERBAL MEDICINE, 2022, 32
  • [24] Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study
    Tanaka, Yoshiya
    Kawai, Shinichi
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2013, 23 (06) : 1045 - 1052
  • [25] A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis
    Aranow, Cynthia
    Cush, John
    Bolster, Marcy B.
    Striebich, Christopher C.
    Dall'era, Maria
    Mackay, Meggan
    Olech, Ewa
    Frech, Tracy
    Box, Jane
    Keating, Richard
    Wasko, Mary Chester
    St Clair, William
    Kivitz, Alan
    Huang, Weiquang
    Ricketts, PetaGay
    Welch, Beverly
    Callahan, Sherrie
    Spychala, Meagan
    Boyle, Karen
    York, Kate
    Keyes-Elstein, Lynette
    Goldmuntz, Ellen
    Diamond, Betty
    Davidson, Anne
    RHEUMATOLOGY, 2020, 59 (07) : 1505 - 1513
  • [26] No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study
    van der Laan, WH
    Ronday, HK
    TeKoppele, JM
    Breedveld, FC
    Huizinga, TWJ
    Verheijen, JH
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (03) : 359 - 362
  • [27] A double-blind placebo-controlled study to determine the effects of risedronate on bone loss in glucocorticoid-treated rheumatoid arthritis
    Eastell, R
    Devogelaer, JP
    Peel, NFA
    Gill, C
    Bax, DE
    deDeuxchaisnes, CN
    Russell, RGG
    OSTEOPOROSIS 1996, 1996, 1118 : 391 - 393
  • [28] LORNOXICAM VERSUS DICLOFENAC IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, MULTICENTER STUDY
    CARUSO, I
    MONTRONE, F
    BOARI, L
    DAVOLI, C
    BEYENE, NB
    CAPORALI, R
    GANDINI, R
    FUMAGALLI, M
    BARATELLI, E
    BROGGINI, M
    CANESI, MB
    MUSCARA, M
    MANZONI, A
    LOCATI, M
    DINGIANNA, E
    FIORENTINI, F
    ADVANCES IN THERAPY, 1994, 11 (03) : 132 - 138
  • [29] PROGLUMETACIN VERSUS INDOMETHACIN IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND MULTICENTER STUDY
    APPELBOOM, T
    FRANCHIMONT, P
    ADVANCES IN THERAPY, 1994, 11 (05) : 228 - 234
  • [30] Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial
    Furuzawa-Carballeda, J.
    Fenutria-Ausmequet, R.
    Gil-Espinosa, V.
    Lozano-Soto, F.
    Teliz-Meneses, M. A.
    Romero-Trejo, C.
    Alcocer-Varela, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (05) : 514 - 520